Cecile Orsini

Title: Cecile Orsini: Innovator in Biotechnological Advancements

Introduction

Cecile Orsini is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of innovative reporter genes and methods for producing recombinant adenoviruses. With a total of 2 patents to her name, her work has had a substantial impact on research and therapeutic applications.

Latest Patents

Cecile Orsini's latest patents include the invention of engineered secreted alkaline phosphatase (SEAP) reporter genes and polypeptides. This invention provides a novel reporter gene, mSEAP, which is capable of being expressed in mammals for extended periods. The patent also discloses nucleic acids encoding the reporter gene, cells and vectors comprising these nucleic acids, and methods for using the reporter gene to identify expression vectors and screen for drug compounds in animals. Additionally, she has developed cells for the production of recombinant adenoviruses, further enhancing the capabilities of biotechnological research.

Career Highlights

Throughout her career, Cecile has worked with notable companies such as Rhone-Poulenc Rorer S.A. and Aventis Pharma S.A. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical and biotechnology sectors.

Collaborations

Cecile has collaborated with esteemed colleagues, including Emmanuelle Vigne and Michel Perricaudet. These partnerships have fostered an environment of innovation and have led to significant advancements in their respective fields.

Conclusion

Cecile Orsini's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in the industry. Her work continues to influence research and development in innovative therapeutic solutions.